Omega-3 Supplements Linked to Fewer Pain Crises in Children With Sickle Cell Disease
In children with sickle cell disease, adding omega-3 to standard therapy was linked to fewer and less severe pain crises than standard therapy alone.
A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
In children with sickle cell disease, adding omega-3 to standard therapy was linked to fewer and less severe pain crises than standard therapy alone.
Nursing mothers who took DHA supplements for 150 days had higher breast milk DHA levels, and their infants showed better growth and neurodevelopmental scores than infants of non-supplemented mothers.
Modern diets have shifted from an ancestral omega-6 to omega-3 ratio of about 1:1 to as high as 25:1, a change linked to brain and cell membrane composition.
A review of human studies found mixed but generally favorable evidence that higher omega-3 fatty acid levels are associated with longer telomeres, a marker linked to cellular aging.
Combining gene-marking, gene-activity, and genetic data suggests omega-3 fatty acids may influence aging-related biology partly through changes in gut bacteria and gene regulation.
Omega-3 supplementation showed small improvements in liver fat and triglycerides in children with fatty liver disease, but little evidence of benefit for liver scarring.